Literature DB >> 12830487

EPO-producing gastric carcinoma in a hemodialysis patient.

Manabu Matsuo1, Shigehiko Koga, Hiroshi Kanetake, Hiroshi Ohtani, Yoshikazu Higami, Isao Shimokawa, Jun-ichi Watanabe.   

Abstract

A case of erythrocytosis caused by gastric cancer that produced erythropoietin is described. To the authors' knowledge, no case of erythropoietin-producing gastric cancer has been reported until now. A 73-year-old man with a 4-year history of maintenance hemodialysis for diabetic nephropathy required phlebotomy. Serum erythropoietin level was 181 mU/mL (181 IU/L). Gastroscopy results showed rough mucosa with hemorrhaging caused by gastric cancer. The patient underwent distal gastrectomy, and serum erythropoietin level decreased to 27.1 mU/mL (27.1 IU/L) by postoperative day 8. Existence of erythropoietin in the tumor tissue was confirmed immunohistochemically. The presence of severe acquired cystic disease of the kidney, renal cell carcinoma, and other malignant tumors should be investigated in hemodialysis patients displaying erythrocytosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12830487     DOI: 10.1016/s0272-6386(03)00425-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Erythrocytosis caused by erythropoietin-producing thymic carcinoma.

Authors:  Wataru Munakata; Kazuteru Ohashi; Koji Sakaguchi; Hirotoshi Horio; Tsunekazu Hishima; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Clin Oncol       Date:  2010-02-24       Impact factor: 3.402

2.  Idiopathic erythrocytosis in a patient on chronic hemodialysis.

Authors:  Dong Hyun Lee; Ji Hye Min; Sang Byung Bae; Hyo Wook Gil; Jong Oh Yang; Eun Young Lee; Sae Yong Hong
Journal:  Kidney Res Clin Pract       Date:  2014-11-27

3.  Erythropoietin-producing tubercle granuloma in a hemodialysis patient.

Authors:  Minoru Satoh; Hiroshi Ueta; Takehiko Tokura; Tamaki Sasaki; Naoki Kashihara
Journal:  BMC Nephrol       Date:  2013-04-21       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.